<DOC>
	<DOCNO>NCT00543309</DOCNO>
	<brief_summary>The staged surgical pathway treat child single ventricle heart defect culminate Fontan operation . In procedure , systemic venous return rerouted directly pulmonary artery , serf separate systemic pulmonary circulation . Although mortality follow Fontan operation uncommon , early postoperative morbidity include prolonged postoperative chest tube drainage hospitalization remain significant . The efficacy empiric inotropic , vasodilator neurohumoral-inhibitory therapy perioperative period unknown practice varies widely center . The investigator propose single-center , randomize , double-blind , phase II clinical trial child undergo Fontan surgery . The investigator plan compare effect perioperative nesiritide , milrinone placebo infusion early postoperative clinical course neurohumoral profile . The investigator hypothesize , compare milrinone placebo group , nesiritide group day alive hospital within first 30 day surgery .</brief_summary>
	<brief_title>Effects Perioperative Nesiritide Milrinone Infusion Recovery From Fontan Surgery</brief_title>
	<detailed_description>The staged surgical pathway treat child single ventricle heart defect culminate Fontan operation . In procedure , systemic venous return rerouted directly pulmonary artery , serf separate systemic pulmonary circulation . Following operation , deoxygenate blood flow passively body lung without pump chamber . Although mortality follow Fontan operation uncommon , early postoperative morbidity include prolonged postoperative chest tube drainage hospitalization remain significant . The efficacy empiric inotropic , vasodilator neurohumoral-inhibitory therapy perioperative period unknown practice varies widely center . We propose single-center , randomize , double-blind , phase II clinical trial child undergo Fontan surgery . We plan compare effect perioperative nesiritide , milrinone placebo infusion early postoperative clinical course neurohumoral profile . The primary aim study determine whether nesiritide , milrinone placebo infusion associate few day alive hospital within 30 day surgery . We hypothesize , compare milrinone placebo group , nesiritide group day alive hospital within first 30 day surgery . Secondary aim determine effect infusion postoperative resource consumption , hemodynamics , arrhythmia , renal function , neurohumoral activation adverse event . Thirty-nine patient per group ( 117 total patient ) enrol three year .</detailed_description>
	<mesh_term>Congenital Abnormalities</mesh_term>
	<mesh_term>Heart Defects , Congenital</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<mesh_term>Milrinone</mesh_term>
	<criteria>Patients undergo elective , primary Fontan operation Children 's Hospital Boston . Revision surgery fail Fontan circulation . Preoperative serum creatinine &gt; 1.5 mg/dL chronic dialysis . The attend surgeon , cardiac anesthesiologist , cardiac intensivist compel indication initiate either nesiritide milrinone outside confines study .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Fontan Operation</keyword>
	<keyword>Cardiopulmonary Bypass</keyword>
	<keyword>Heart Defects , Congenital</keyword>
	<keyword>Milrinone</keyword>
	<keyword>Natriuretic peptide , brain</keyword>
</DOC>